|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.246 SEK | -1.89% |
|
-0.95% | -36.75% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 185M 19.05M 16.75M 15.59M 14.32M 26.88M 1.83B 27.24M 72.37M 902M 71.51M 69.97M 3.12B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 185M 19.05M 16.75M 15.59M 14.32M 26.88M 1.83B 27.24M 72.37M 902M 71.51M 69.97M 3.12B | EV / Sales 2026 * |
1.82x | EV / Sales 2027 * | 1.31x |
| Free-Float |
81.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| 1 day | -1.89% | ||
| 1 week | -0.95% | ||
| Current month | +0.48% | ||
| 1 month | +2.13% | ||
| 3 months | -18.99% | ||
| 6 months | -29.20% | ||
| Current year | -36.75% |
| 1 week | 1.23 |  | 1.35 |
| 1 month | 1.17 | | 1.43 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.38 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 65.7 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
| Chairman | 68 | 2023-02-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 7/1/26 | Buy | Chief Technology Officer | 4,016,742 | 5,035.0256% | ||
| 7/1/26 | Buy | Chief Executive Officer | 183,858 | 230.4678% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | -0.95% | -62.58% | -84.42% | 19.47M | |
| +0.13% | +4.41% | +47.35% | +163.20% | 1,067B | |
| +0.97% | +6.88% | +58.02% | +53.12% | 635B | |
| -0.94% | +1.39% | +35.02% | +72.60% | 458B | |
| +1.41% | +8.56% | +38.93% | +32.17% | 347B | |
| +1.28% | +4.40% | +38.42% | +41.62% | 295B | |
| +1.72% | +4.10% | +19.31% | +20.45% | 262B | |
| +1.84% | -0.46% | -27.78% | -38.65% | 216B | |
| +0.06% | +3.32% | +22.73% | +59.40% | 203B | |
| +0.94% | -2.02% | +12.32% | +70.59% | 161B | |
| Average | +0.55% | +1.59% | +18.17% | +39.01% | 364.35B | |
| Weighted average by Cap. | +0.60% | +2.25% | +36.75% | +78.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.49M 9.22M 8.58M 7.88M 14.8M 1.01B 14.99M 39.84M 497M 39.36M 38.52M 1.72B | 142M 14.58M 12.82M 11.93M 10.96M 20.57M 1.4B 20.84M 55.38M 690M 54.72M 53.54M 2.39B |
| Net income | -32.6M -3.35M -2.95M -2.74M -2.52M -4.73M -321M -4.79M -12.73M -159M -12.58M -12.31M -549M | 33.3M 3.42M 3.01M 2.8M 2.57M 4.83M 328M 4.89M 13.01M 162M 12.85M 12.57M 560M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | SEK 1.246 | -1.89% | 447,368 |
| 26-07-24 | SEK 1.270 | -0.31% | 395,448 |
| 26-07-23 | SEK 1.274 | -4.21% | 36,950 |
| 26-07-22 | SEK 1.330 | -1.34% | 67,619 |
| 26-07-21 | SEK 1.348 | +7.15% | 166,477 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
